Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 26.00
-0.50 (-1.89%)
Jan 23, 2026, 4:24 PM CET
Poltreg Revenue
In the year 2024, Poltreg had annual revenue of 350.00K PLN, down -74.98%.
Revenue
350.00K
Revenue Growth
-74.98%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
123.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350.00K | -1.05M | -74.98% |
| Dec 31, 2023 | 1.40M | 400.00K | 40.04% |
| Dec 31, 2022 | 999.00K | -100.00K | -9.10% |
| Dec 31, 2021 | 1.10M | 399.00K | 57.00% |
| Dec 31, 2020 | 700.00K | 200.00K | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 295.81M |
| Ryvu Therapeutics | 90.41M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Urteste | 1.80M |
| Pharmena | 1.27M |